Cellular and gene therapies represent a new wave of rational therapeutic design by genetically modifying cells to carry out therapeutic tasks. While gene therapies use nucleic acids, cell therapies involve use of cellular material to replace missing functional proteins or alter cellular networks responsible for a diseased state. An increased understanding of disease-associated biological pathways and our ability to genetically encode cell and gene therapeutic programs have made treating monogenic disorders and hematological malignancies possible over the past two decades.

[EPISODE 25] Adam Stasio Talks, Large Data Sets, Breaking Down Problems, and Tech-Driven Solutions
On this episode of Molecular Moments, Jim McNally, Ph.D., speaks with Adam Stasio, president of SciMed, whose mission is to